Impax Laboratories (IPXL) Initiates Challenges to Abbott's Patents in Connection to TRICOR
Tweet Send to a Friend
Impax Laboratories, Inc. (NASDAQ: IPXL) has initiated a challenge of the patents listed by Abbott Laboratories (NYSE: ABT) in connection ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
